A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William Smith, MD
Celgene
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uab Dermatology
Birmingham, Alabama, United States
- the Regents of the University of California
Irvine, California, United States
- Medical Faculty Associates
Washington D.C., District of Columbia, United States
- Advanced Pharma, Cr, Llc
Miami, Florida, United States
- University of Miami - Department of Dermatology
Miami, Florida, United States
- Rush Medical Center
Chicago, Illinois, United States
- North Shore University Health System
Skokie, Illinois, United States
- Siu School of Medicine
Springfield, Illinois, United States
- Tulane University School of Medicine
New Orleans, Louisiana, United States
- John Hopkins University
Baltimore, Maryland, United States
- Boston Cancer Center
Boston, Massachusetts, United States
- University of Minnesota-Department of Dermatology
Minneapolis, Minnesota, United States
- University of Rochester Medical Center
Rochester, New York, United States
- Ohio State Univ Medical Center, Division of Dermatology
Columbus, Ohio, United States
- Rhode Island Hospital University Dermatology, Inc.
Providence, Rhode Island, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Dermatology and Research
Dallas, Texas, United States
- University of Texas Dermatology
Houston, Texas, United States
- Sun Research Institute
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Nov 2011
- Primary completion
- 30 Jul 2012
- Completion
- 30 Jul 2012
- Last update posted
- 19 Nov 2019
- Registered enrollment
- 5
- Registry id
- NCT01466725
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.